Tandem autologous plus non-myeloablative allogeneic stem cell transplantation in relapsed multiple myeloma: an Australian joint report from the Alfred and Myeloma and Related Diseases Registry

被引：0
|
作者：
Tedjaseputra, Aditya [1 ]
Das, Tongted [1 ]
Wellard, Cameron [2 ]
Spencer, Andrew [3 ]
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Transfus Res Unit, Clayton, Vic, Australia
[3] Monash Univ, Alfred Hlth, Clayton, Vic, Australia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-218
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [41] Tandem autologous plus reduced-intensity allogeneic stem cell transplantation without standard immunosuppression in young patients with relapsed and refractory multiple myeloma
    Pokrovskaya, O.
    Mendeleeva, L.
    Makunina, E.
    Kuzmina, L.
    Firsova, M.
    Nareyko, M.
    Urnova, E.
    Galtseva, I.
    Sorokina, T.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S300 - S300
  • [42] Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma
    Ozturk, Hba
    Dikyar, Aa
    Yegin, Za
    Kaynar, La
    Can, F.
    Ozkurt, Zn
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (12) : 1405 - 1409
  • [43] Significant graft-vs-myeloma (GvM) effect after non-myeloablative allogeneic transplantation in multiple myeloma (MM).
    Badros, A
    Tricot, G
    Morris, C
    Fox, M
    Munshi, N
    Spoon, D
    Martin, S
    Toor, A
    Zangari, M
    Fassas, A
    Desikan, R
    Anaissie, E
    Barlogie, B
    BLOOD, 2000, 96 (11) : 352B - 352B
  • [44] Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience
    Nguyen, Phillip C.
    Muirhead, Jenny
    Tan, Joanne
    Kalff, Anna
    Bergin, Krystal
    Walker, Patricia
    Spencer, Andrew
    INTERNAL MEDICINE JOURNAL, 2022, 52 (07) : 1263 - 1267
  • [45] IMPACT OF T CELL DOSE ON OUTCOMES OF NON-MYELOABLATIVE ALLOGENEIC TRANSPLANTS IN MULTIPLE MYELOMA
    Nair, A.
    Das, T.
    Walker, T.
    Kalff, A.
    Bergin, K.
    Hocking, J.
    Avery, S.
    Curtis, D.
    Patil, S.
    Klarica, D.
    Muirhead, J.
    Reynolds, J.
    Spencer, A.
    HAEMATOLOGICA, 2016, 101 : 620 - 620
  • [46] Salvage Tandem Autologous Stem Cell Transplant with Consolidation for Relapsed Multiple Myeloma
    Abbi, Kama Kant Singh
    Behrends, Sonya
    Silverman, Margarida
    Farooq, Umar
    Nadiminti, Kalyan
    Tricot, Guido J.
    BLOOD, 2015, 126 (23)
  • [47] A non-myeloablative regimen of fludarabine and melphalan is safe and well tolerated for allogeneic transplantation in multiple myeloma
    Qazilbash, Muzaffar H.
    Saliba, Rima M.
    Parikh, Gaurav C.
    Hosing, Chitra
    Mendoza, Floralyn
    Weber, Donna M.
    Wang, Michael
    Thomas, Sheeba K.
    Flosser, Thuy S.
    Kebriaei, Partow
    Popat, Uday
    Alousi, Amin M.
    De Lima, Marcos
    Champlin, Richard E.
    Giralt, Sergio A.
    BLOOD, 2007, 110 (11) : 890A - 890A
  • [48] Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Followed by Bortezomib Maintenance Therapy for High Risk Multiple Myeloma
    Green, Damian J.
    Maloney, David G.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Martin, Paul J.
    Becker, Pamela S.
    Georges, George E.
    Bouvier, Michelle E.
    Storb, Rainer
    Mielcarek, Marco B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S215 - S215
  • [49] Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
    Minnema, M. C.
    van de Donk, N. W. C. J.
    Zweegman, S.
    Hegenbart, U.
    Schonland, S.
    Raymakers, R.
    Zijlmans, J. M. J. M.
    Kersten, M. J.
    Bos, G. M. J.
    Lokhorst, H. M.
    BONE MARROW TRANSPLANTATION, 2008, 41 (09) : 779 - 784
  • [50] Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma
    Raab, MS
    Cremer, FW
    Breitkreutz, IN
    Gerull, S
    Luft, T
    Benner, A
    Goerner, M
    Ho, AD
    Goldschmidt, H
    Moos, M
    ANNALS OF ONCOLOGY, 2005, 16 (04) : 611 - 617
12345